Yatırımcı.AI

HBV vs RS1 Fund Comparison

Price, period returns, size, investor count and risk score of HBV (Hedef Portföy Doruk Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) and RS1 (Rota Portföy Birinci Kısa Vadeli Serbest Fon) side by side.

SPK decided to liquidate HBV in bulletin 2026/60 dated September 17, 2026; no buy or redemption orders are executed in the fund. Its returns in this comparison are based on the last price published on TEFAS (November 2, 2026). HBV fund page · SPK bulletin 2026/60

HBVRS1
StockFund

If You Had Invested TRY 10,000

Metric Comparison

HBV vs RS1 Fund Comparison
MetricHBVRS1Category median
Daily−2.20%0.30%0.16%
1 week−2.05%0.67%0.46%
1 month−99.91%2.65%1.10%
3 months−99.91%9.35%3.53%
6 months−99.89%21.29%8.53%
YTD−99.84%37.87%16.18%
1 year−99.85%46.89%19.94%
3 years−99.76%—103.56%
Returns are based on prices as of November 2, 2026; the fund with the higher return or the lower risk score counts as the leader.

Popular Comparisons

Popular Fund Comparisons

Related Pages

About the HBV vs RS1 Comparison

The price, returns, size and risk of HBV (Hedef Portföy Doruk Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) and RS1 (Rota Portföy Birinci Kısa Vadeli Serbest Fon) are compared side by side as of November 2, 2026. Of the 10 metrics compared, HBV leads in 0 and RS1 leads in 10. HBV is a Hedge Fund fund managed by Hedef Portföy Yönetimi A.Ş.; RS1 is a Hedge Fund fund managed by Rota Portföy Yönetimi A.Ş..

Highlights: Daily: RS1 leads (0.30% vs −2.20%). 1 week: RS1 leads (0.67% vs −2.05%). 1 month: RS1 leads (2.65% vs −99.91%). 3 months: RS1 leads (9.35% vs −99.91%). 6 months: RS1 leads (21.29% vs −99.89%). YTD: RS1 leads (37.87% vs −99.84%). 1 year: RS1 leads (46.89% vs −99.85%). Size (TRY): RS1 leads (1.1B vs 980.4K). Investors: RS1 leads (140 vs 17). Risk: RS1 leads (2 vs 7).

Frequently Asked Questions

Year to date HBV returned −99.84% and RS1 returned 37.87%; over the last year HBV returned −99.85% and RS1 returned 46.89%. Over the last month HBV returned −99.91% and RS1 returned 2.65%. Past performance does not indicate future returns.

As of November 2, 2026, HBV has a size of TRY 980.4K with 17 investors, while RS1 has a size of TRY 1.1B with 140 investors. RS1 leads in size and RS1 leads in investor count.

The CMB risk score of HBV is 7 out of 7 and that of RS1 is 2. The risk score reflects the historical volatility of the fund price; 1 is the lowest and 7 the highest risk. A lower score means less volatility, not a guarantee of higher returns.